Multiple myeloma is a complex, malignant blood disease that affects individuals over the age of 65. This disease is characterized by the abnormal accumulation of plasma cells in the bone marrow and organs, leading to bone loss, fractures, and organ dysfunction. These symptoms make it difficult to diagnose the disease, often resulting in complications and delayed treatment.
The Central Institute of Hematology and Blood Transfusion treats approximately 1,000 cases of multiple myeloma each year, with about 150 new cases being discovered annually. Unfortunately, many individuals are unaware of this disease due to its varied symptoms and lack of awareness. Symptoms can range from bone pain to kidney failure, fatigue, recurrent infections and even unrelated symptoms or conditions that may have been misdiagnosed as something else.
Dr. Vu Duc Binh, Deputy Director at the Central Institute of Hematology and Blood Transfusion highlights how challenging it is to diagnose multiple myeloma due to its diverse manifestations. About 10% of cases are mild and require specialized hematological evaluation. The institute has invested in new diagnostic technologies to improve detection rates and treatment outcomes for patients with multiple myeloma.
Currently there is no complete cure for multiple myeloma; instead patients undergo long-term maintenance treatment to manage their symptoms. Treatment regimens involve regular hospital visits for injections which can be financially burdensome for many people. Some patients opt for oral medications but accessibility and insurance coverage remain significant barriers to treatment compliance.
Healthcare providers emphasize the importance of early detection and accessibility to appropriate treatments to improve outcomes for patients with multiple myeloma. They recommend incorporating oral medications into health insurance coverage to enhance patient compliance and reduce treatment abandonment rates. By addressing these challenges healthcare providers can better support individuals living with multiple myeloma and improve their quality of life overall.
In summary: Multiple Myeloma: A Complex Disease Requiring Early Detection & Appropriate Treatments
Multiple Myeloma is a complex blood disease that affects older adults more commonly than younger ones.
It’s characterized by an abnormal accumulation of plasma cells in bones and organs leading to bone loss, fractures, organ dysfunction.
Diagnosing this disease can be difficult due its diverse manifestations such as bone pain, anemia or kidney failure.
Central Institute of Hematology & Blood Transfusion treats around 1000 cases annually with about 150 new ones being discovered every year.
Dr Vu Duc Binh emphasizes on the challenges in diagnosing this disease due
